WORLAND STEPHEN T 4
4 · Tracon Pharmaceuticals, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
WORLAND STEPHEN T
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-14+15,750→ 15,750 totalExercise: $1.30Exp: 2032-06-13→ Common Stock (15,750 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).